Episode 73
Zepbound - Tirzepatide for obesity approval
Drs. Karl and Spencer discuss how tirzepatide is now approved for obesity. Learn: When will it be available How much will is cost Any differences compared to Mounjaro Surmount 3 trial
November 10, 202323m 5s
Audio is streamed directly from the publisher (injector.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Drs. Karl and Spencer discuss how tirzepatide is now approved for obesity.
Learn:
- When will it be available
- How much will is cost
- Any differences compared to Mounjaro
- Surmount 3 trial
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.